Lithium Ion

Lithium Ion

SCHEMBL7698448

CN(CC(=O)[O-])C[C@H]1CCc2ccc(F)cc2[C@H]1c1ccccc1.[Li+]

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 1/20 0.54
MTNR1A P48039 2/20 0.44
MTNR1B P49286 2/20 0.44
TRPM8 Q7Z2W7 1/20 0.38
HTR6 P50406 3/20 0.38
SIGMAR1 Q99720 2/20 0.37
TACR1 P25103 1/20 0.36
DRD5 P21918 4/20 0.35
PIN1 Q13526 2/20 0.35
BLM P54132 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL7706198 0.94 SLC6A9 (0.46) SLC6A9MTNR1AMTNR1BTRPM8HTR6
Lithium Ion SCHEMBL7703444 0.92 SLC6A9 (0.62) SLC6A9MTNR1AMTNR1BHTR6SIGMAR1
SCHEMBL7698449 0.90 SLC6A9 (0.62) SLC6A9MTNR1AMTNR1BTRPM8HTR6
Lithium Ion SCHEMBL7704198 0.87 SLC6A9 (0.51) SLC6A9MTNR1AMTNR1BSIGMAR1PIN1
Lithium Ion SCHEMBL7706983 0.86 SLC6A9 (0.71) SLC6A9MTNR1AMTNR1B
Lithium Ion SCHEMBL7698371 0.85 SLC6A9 (0.53) SLC6A9MTNR1AMTNR1BHTR6
Lithium Ion SCHEMBL7702844 0.82 SLC6A9 (0.63) SLC6A9MTNR1AMTNR1BHTR6SIGMAR1
Lithium Ion SCHEMBL7702768 0.82 SLC6A9 (0.60) SLC6A9MTNR1AMTNR1BTACR1
Lithium Ion SCHEMBL7702608 0.81 SLC6A9 (0.52) SLC6A9MTNR1AMTNR1BTRPM8HTR6
Lithium Ion SCHEMBL7698462 0.80 SLC6A9 (0.69) SLC6A9MTNR1AMTNR1BTRPM8TACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100769-B1 AMINOMETHYLCARBOXYLIC ACID DERIVATIVES AKZO NOBEL NV (NL) 2002-12-04 EP disclosed
US-6410592-B1 THERAPY FOR CENTRAL NERVOUS SYSTEM DISORDERS, PSYCHOLOGICAL DISORDERS AKZO NOBEL N.V. (NL) 2002-06-25 US disclosed